PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme

A Contract Award Notice
by PUBLIC HEALTH ENGLAND

Source
Contracts Finder
Type
Framework (Services)
Duration
16.5 month
Value
£80K
Sector
HEALTH
Published
17 Aug 2021
Delivery
17 Aug 2021 to 30 Dec 2022
Deadline
20 Jul 2021 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Minimum acceptable performance criteria for designing test accuracy studies of cfDNA within the UK Sickle Cell and Thalassaemia Screening Programme: a decision analytic model.

Award Detail

1 Costello Medical (London)
  • Value: £80,464

CPV Codes

  • 75122000 - Administrative healthcare services

Indicators

  • Contract is suitable for SMEs.

Reference

Domains